FLUCELVAX QUADRIVALENT
Biological
Seqirus USA Inc
Total Payments
$388,788
Transactions
9,612
Doctors
6,980
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $154,502 | 3,830 | 3,281 |
| 2022 | $110,355 | 4,130 | 3,501 |
| 2021 | $123,931 | 1,652 | 1,518 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $171,607 | 9,530 | 44.1% |
| Unspecified | $109,962 | 21 | 28.3% |
| Consulting Fee | $68,316 | 30 | 17.6% |
| Honoraria | $27,713 | 19 | 7.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,378 | 6 | 2.2% |
| Travel and Lodging | $2,775 | 4 | 0.7% |
| Education | $37.24 | 2 | 0.0% |
Payments by Type
General
$278,826
9,591 transactions
Research
$109,962
21 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects | Seqirus USA Inc | $102,337 | 0 |
| Efficacy Study With QIVc in Pediatric Subjects | Seqirus USA Inc | $4,500 | 1 |
| Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects 2 to <18 Years of Age | Seqirus USA Inc | $3,125 | 1 |
Top Doctors Receiving Payments for FLUCELVAX QUADRIVALENT
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Lisa Dabu | — | Bronx, NY | $102,433 | 20 |
| , MD | Pediatrics | Pittsburgh, PA | $17,052 | 5 |
| , MD | Pediatrics | Birmingham, AL | $15,838 | 14 |
| , MD | Pediatrics | Louisville, KY | $8,700 | 2 |
| , MD | Pediatrics | Pittsburgh, PA | $8,643 | 4 |
| , MD | Pediatric Infectious Diseases | Nashville, TN | $7,625 | 7 |
| , RN, MSN, PHD | Family | Louisville, KY | $6,461 | 3 |
| , MD | Pediatrics | Boston, MA | $6,039 | 3 |
| , MD | Pediatric Infectious Diseases | Houston, TX | $4,216 | 2 |
| , MD | Pediatric Infectious Diseases | Aurora, CO | $4,079 | 2 |
| , DNP, RN, CPNP-PC | Pediatrics | League City, TX | $3,840 | 5 |
| , M.D | Pediatric Infectious Diseases | Las Vegas, NV | $3,768 | 4 |
| , MD | Pediatrics | Pittsburgh, PA | $3,300 | 1 |
| , M.D | Pediatrics | Lake Forest, CA | $3,240 | 2 |
| Anita Chandra Puri | Pediatrics | Chicago, IL | $3,216 | 1 |
| , MD | Adult Medicine | Milwaukee, WI | $3,200 | 1 |
| , ARNP | Family | Amherst, NH | $2,880 | 4 |
| , MD | Pediatrics | Providence, RI | $2,388 | 3 |
| , MD | Clinical & Laboratory Immunology | Doylestown, PA | $2,384 | 1 |
| , PNP | Pediatrics | Boston, MA | $2,380 | 2 |
| Yufei Ge | Family Medicine | Pittsburgh, PA | $1,179 | 1 |
| , DO | Neonatal-Perinatal Medicine | Los Angeles, CA | $1,158 | 1 |
| , M.D | Pediatric Infectious Diseases | Corpus Christi, TX | $1,158 | 1 |
| , MD | Pediatric Infectious Diseases | Cincinnati, OH | $1,158 | 1 |
| , MD | Pediatrics | Manhasset, NY | $1,158 | 1 |
Ad
Manufacturing Companies
- Seqirus USA Inc $388,788
Product Information
- Type Biological
- Total Payments $388,788
- Total Doctors 6,980
- Transactions 9,612
About FLUCELVAX QUADRIVALENT
FLUCELVAX QUADRIVALENT is a biological associated with $388,788 in payments to 6,980 healthcare providers, recorded across 9,612 transactions in the CMS Open Payments database. The primary manufacturer is Seqirus USA Inc.
Payment data is available from 2021 to 2023. In 2023, $154,502 was paid across 3,830 transactions to 3,281 doctors.
The most common payment nature for FLUCELVAX QUADRIVALENT is "Food and Beverage" ($171,607, 44.1% of total).
FLUCELVAX QUADRIVALENT is associated with 3 research studies, including "Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects" ($102,337).